A detailed history of Atlas Capital Advisors LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 4,440 shares of RDY stock, worth $61,316. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,440
Previous 888 400.0%
Holding current value
$61,316
Previous $70.6 Million 0.63%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$13.99 - $79.75 $49,692 - $283,272
3,552 Added 400.0%
4,440 $70.1 Million
Q3 2024

Nov 05, 2024

BUY
$75.41 - $84.21 $7,993 - $8,926
106 Added 13.55%
888 $70.6 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $48,405 - $56,906
782 New
782 $52.3 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.29B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.